GAMMA Investing LLC Increases Position in Phibro Animal Health Corporation (NASDAQ:PAHC)

GAMMA Investing LLC boosted its holdings in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 2,011.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,718 shares of the company's stock after purchasing an additional 34,979 shares during the quarter. GAMMA Investing LLC owned about 0.09% of Phibro Animal Health worth $784,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Sterling Capital Management LLC raised its position in Phibro Animal Health by 2.4% in the 4th quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock valued at $394,000 after purchasing an additional 448 shares during the last quarter. Rhumbline Advisers raised its position in Phibro Animal Health by 0.6% in the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock valued at $1,608,000 after purchasing an additional 484 shares during the last quarter. Los Angeles Capital Management LLC raised its position in Phibro Animal Health by 2.1% in the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock valued at $505,000 after purchasing an additional 503 shares during the last quarter. New York State Teachers Retirement System raised its position in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Phibro Animal Health in the 4th quarter valued at $29,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Stock Performance

Phibro Animal Health stock traded down $0.08 during trading hours on Friday, reaching $23.88. 247,450 shares of the stock were exchanged, compared to its average volume of 207,387. The stock has a market cap of $967.86 million, a P/E ratio of 30.62, a P/E/G ratio of 0.45 and a beta of 0.74. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $26.55. The firm's 50 day moving average is $21.85 and its 200 day moving average is $21.92.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The company had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. Analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.01%. Phibro Animal Health's dividend payout ratio is presently 61.54%.

Wall Street Analyst Weigh In

Several analysts recently commented on PAHC shares. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a research report on Monday, June 16th. Finally, Morgan Stanley upped their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $20.80.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.